Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prostate cancer early detection. Clinical practice guidelines in oncology.

Literature DB >> 17692177

Prostate cancer early detection. Clinical practice guidelines in oncology.

Mark H Kawachi, Robert R Bahnson, Michael Barry, Peter R Carroll, H Ballentine Carter, William J Catalona, Jonathan I Epstein, Ruth B Etzioni, George P Hemstreet, Richard J Howe, Jeff D Kopin, Paul H Lange, Hans Lilja, James Mohler, Judd Moul, Robert B Nadler, Stephan Patterson, Alan Pollack, Joseph C Presti, Antoinette M Stroup, Donald A Urban, Robert Wake, John T Wei.

Abstract

Entities: Disease

Mesh：

Year: 2007 PMID： 17692177

Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial.

Authors: Stephen B Williams; Simpa Salami; Meredith M Regan; Donna P Ankerst; John T Wei; Mark A Rubin; Ian M Thompson; Martin G Sanda
Journal: Cancer Date: 2011-10-17 Impact factor: 6.860

2. Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age.

Authors: Derya Tilki; Valentin Maurer; Raisa S Pompe; Felix K Chun; Felix Preisser; Alexander Haese; Markus Graefen; Hartwig Huland; Philipp Mandel
Journal: World J Urol Date: 2019-04-02 Impact factor: 4.226

3. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.

Authors: Iris Lansdorp-Vogelaar; Roman Gulati; Angela B Mariotto; Clyde B Schechter; Tiago M de Carvalho; Amy B Knudsen; Nicolien T van Ravesteyn; Eveline A M Heijnsdijk; Chester Pabiniak; Marjolein van Ballegooijen; Carolyn M Rutter; Karen M Kuntz; Eric J Feuer; Ruth Etzioni; Harry J de Koning; Ann G Zauber; Jeanne S Mandelblatt
Journal: Ann Intern Med Date: 2014-07-15 Impact factor: 25.391

4. Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.

Authors: Simpa S Salami; Folke Schmidt; Bharathi Laxman; Meredith M Regan; David S Rickman; Douglas Scherr; Gerardina Bueti; Javed Siddiqui; Scott A Tomlins; John T Wei; Arul M Chinnaiyan; Mark A Rubin; Martin G Sanda
Journal: Urol Oncol Date: 2011-05-19 Impact factor: 3.498

5. Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older.

Authors: Richard Berges; Matthias Oelke
Journal: World J Urol Date: 2011-01-08 Impact factor: 4.226

6. Mortality results from a randomized prostate-cancer screening trial.

Authors: Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal: N Engl J Med Date: 2009-03-18 Impact factor: 91.245

Prostate cancer early detection. Clinical practice guidelines in oncology.

1. Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial.

2. Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age.

3. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.

4. Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.

5. Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older.

6. Mortality results from a randomized prostate-cancer screening trial.

7. Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer.

8. Prostate-specific antigen testing among the elderly in community-based family medicine practices.

9. Oxidative stress measured by thioredoxin reductase level as potential biomarker for prostate cancer.

10. Treatment and survival outcomes in young men diagnosed with prostate cancer: a Population-based Cohort Study.